« Vous réfléchissez trop à ce que vous avez dit ? », interroge le Dr Rodrigo Braga, neurologue à la Feinberg School of Medicine (Chicago). Cette recherche, menée avec son équipe de la Northwestern ...

Cette recherche publiée dans la revue Frontiers in Behavioral Neuroscience, non seulement souligne l’importance de la ...

S’il affecte plus de 17 millions de personnes dans le monde, le syndrome de fatigue chronique (SFC) reste mal compris, mal diagnostiqué et mal traité. Et si une simple électrode pouvait détecter, de ...

Faire travailler son cerveau évite ou ralentit son déclin. Mais pas seulement. Cela bénéficie aussi à la santé physique. Et l'endurance cérébrale est tout aussi important que l’endurance physique, ...

Paulson Investment Company, LLC is acting as the exclusive placement agent in connection with the offering.

The closing of the Offering is expected to occur on or about November 25, 2024, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds from this ...

LAS VEGAS, Nov. 21, 2024 (GLOBE NEWSWIRE) -- BioAdaptives Inc. (OTC: BDPT) ushered in a new direction by appointing James Keener as CEO on May 21, 2024. Previous management retired, and Keener began ...

Orion Research Foundation sr is distributing EUR 1,109,000 in research grants based on applications for 2025. Orion Research Foundation awards grants of max EUR 50,000 for 19 researchers for ...

“We are grateful to Avenue Capital for the support they have demonstrated during this challenging time,” stated Michael Rowe, Chief Executive Officer of Eyenovia. “We took immediate steps to ...

The full text of, inter alia, the resolutions proposed and passed at the Annual General Meeting and General Meeting can be found in the Notice of the General Meeting on the Company's website at: https ...

G&A expenses remain stable at around CHF 1.9 million for both nine-month period ended September 30, 2024 and 2023. G&A expenses decreased by CHF 0.1 million to CHF 0.5 million during the third quarter ...

CAMBRIDGE, Mass., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that Eric Shaff, President and Chief Executive ...